Development and evaluation of insulin-loaded chitosan nanoparticles incorporated into HPMC/PVA topical film for diabetic wound management

Introduction Chronic diabetic wounds, particularly foot ulcers, exhibit delayed healing due to impaired tissue repair and infection risk. Topical insulin has shown wound-healing benefits, while nanotechnology-based carriers such as chitosan nanoparticles embedded in polymeric films can enable sustained and localized delivery to enhance therapeutic outcomes. Methods Insulin-loaded chitosan nanoparticles were prepared by ionic gelation using sodium tripolyphosphate (TPP). Eight formulations (F1–F8) were developed and evaluated for particle size, polydispersity index (PDI), zeta potential, and encapsulation efficiency. Four optimized nanoparticle batches (F1–F4) were incorporated into hydroxypropyl methylcellulose (HPMC)/polyvinyl alcohol (PVA) films. The films were assessed for mechanical properties, surface pH, drug content, and in vitro insulin release using dialysis and Franz diffusion cell techniques. Release kinetics were analysed using established mathematical models. Results Optimized nanoparticles showed a mean particle size of 129 nm, a PDI of 0.139, a zeta potential of + 16.27 mV, and encapsulation efficiency of 80–95%. The selected film (F4) exhibited good mechanical integrity (>100 folding cycles), skin-compatible pH (6.57), and high drug content (92.39%). In vitro release demonstrated sustained insulin release from nanoparticles (70.31% at 48 h) and films (66.15% at 48 h), while plain insulin solution released 99.01% within 6 h. Release followed first-order kinetics (r² = 0.9849), suggesting diffusion-controlled behaviour. Discussion Embedding insulin-loaded nanoparticles into HPMC/PVA films improved release sustainability and stability compared to conventional insulin solutions, indicating enhanced suitability for chronic wound applications. Conclusion The optimized nanoparticle-embedded film (F4) represents a promising platform for sustained topical insulin delivery, offering favourable physicochemical and mechanical attributes for diabetic wound management.

Authors

Institutions

Publication Details

Journal
Next Nanotechnology
Published
2026-09-18
DOI
https://doi.org/10.1016/j.nxnano.2026.100791
Primary Topic
Wound Healing and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Development and evaluation of insulin-loaded chitosan nanoparticles incorporated into HPMC/PVA topical film for diabetic wound management

Vikas Jhawat, Lalit Singh, Saahil Arora, Monika et al.
Next Nanotechnology
Wound Healing and Treatments
article

Development and evaluation of insulin-loaded chitosan nanoparticles incorporated into HPMC/PVA topical film for diabetic wound management

Vikas Jhawat, Lalit Singh, Saahil Arora, Monika, Rahul Pratap Singh
article en

Abstract

Introduction Chronic diabetic wounds, particularly foot ulcers, exhibit delayed healing due to impaired tissue repair and infection risk. Topical insulin has shown wound-healing benefits, while nanotechnology-based carriers such as chitosan nanoparticles embedded in polymeric films can enable sustained and localized delivery to enhance therapeutic outcomes. Methods Insulin-loaded chitosan nanoparticles were prepared by ionic gelation using sodium tripolyphosphate (TPP). Eight formulations (F1–F8) were developed and evaluated for particle size, polydispersity index (PDI), zeta potential, and encapsulation efficiency. Four optimized nanoparticle batches (F1–F4) were incorporated into hydroxypropyl methylcellulose (HPMC)/polyvinyl alcohol (PVA) films. The films were assessed for mechanical properties, surface pH, drug content, and in vitro insulin release using dialysis and Franz diffusion cell techniques. Release kinetics were analysed using established mathematical models. Results Optimized nanoparticles showed a mean particle size of 129 nm, a PDI of 0.139, a zeta potential of + 16.27 mV, and encapsulation efficiency of 80–95%. The selected film (F4) exhibited good mechanical integrity (>100 folding cycles), skin-compatible pH (6.57), and high drug content (92.39%). In vitro release demonstrated sustained insulin release from nanoparticles (70.31% at 48 h) and films (66.15% at 48 h), while plain insulin solution released 99.01% within 6 h. Release followed first-order kinetics (r² = 0.9849), suggesting diffusion-controlled behaviour. Discussion Embedding insulin-loaded nanoparticles into HPMC/PVA films improved release sustainability and stability compared to conventional insulin solutions, indicating enhanced suitability for chronic wound applications. Conclusion The optimized nanoparticle-embedded film (F4) represents a promising platform for sustained topical insulin delivery, offering favourable physicochemical and mechanical attributes for diabetic wound management.

Next NanotechnologyVol. 10
Chhatrapati Shahu Ji Maharaj University (IN), GD Goenka University (IN)
Responsible consumption and production
Openalex Percentile: Top 15%
Wound Healing and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.